+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
530207 BRAWN

Brawn Biotech Share Price

 

 

Brawn Biotech live price: ₹19.5. It opened at ₹18 vs previous close ₹19; intraday high/low: ₹20/₹18. The 50 & 200 DMA stand at ₹20.58/₹20.34.

Brawn Biotech Performance

  • Today's Low
  • ₹18
  • Today's High
  • ₹20
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹24
  • Open Price₹18
  • Previous Close₹19
  • Volume1,670
  • 50 DMA₹20.58
  • 100 DMA₹20.54
  • 200 DMA₹20.34

Brawn Biotech Chart

Investment Returns

  • Over 1 Month -4.88%
  • Over 3 Month -3.47%
  • Over 6 Month -2.5%
  • Over 1 Year + 14.71%

Smart Investing Starts Here Start SIP with Brawn Biotech for Steady Growth!

Invest Now

Brawn Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 6.2
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 6
  • P/B Ratio
  • 1.3
  • Average True Range
  • 0.75
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0
  • RSI
  • 41.81
  • MFI
  • 20.52

Brawn Biotech Financials

Brawn Biotech Technicals

EMA & SMA

Current Price
₹19.50
+ 0.45 (2.36%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹20.50
  • 50 Day
  • ₹20.60
  • 100 Day
  • ₹20.50
  • 200 Day
  • ₹20.30

Resistance and Support

19.05 Pivot Speed
  • R3 21.31
  • R2 20.41
  • R1 19.95
  • S1 18.59
  • S2 17.69
  • S3 17.23

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Brawn Biotech has an operating revenue of Rs. 16.98 Cr. on a trailing 12-month basis. An annual revenue growth of 29% is outstanding, Pre-tax margin of 0% needs improvement, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 56 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Brawn Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-05-26 Audited Results
2025-02-12 Quarterly Results

Brawn Biotech Shareholding Pattern

52.94%
0.35%
0%
0%
0%
30.49%
16.22%

Brawn Biotech FAQs

Brawn Biotech share price is ₹19 As on 15 June, 2026 | 10:59

The Market Cap of Brawn Biotech is ₹5.9 Cr As on 15 June, 2026 | 10:59

The P/E ratio of Brawn Biotech is 6.2 As on 15 June, 2026 | 10:59

The PB ratio of Brawn Biotech is 1.3 As on 15 June, 2026 | 10:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23